Literature DB >> 30769166

Successful treatment of chromoblastomycosis using ALA-PDT in a patient with leukopenia.

Xiaowen Huang1, Kai Han1, Li Wang1, Xiaoming Peng1, Kang Zeng1, Li Li2.   

Abstract

Chromoblastomycosis is a long-term fungal infection of the skin and subcutaneous tissue, usually presenting as partial hypertrophic and warty plaques. Effective treatment is necessary to control the development of lesions, especially in patients with associated diseases. But till now, the treatment is still a challenge. Photodynamic therapy (PDT) is an efficient and non-invasive treatment option. Here, we reported the case of a 52-year-old male with refractory chromoblastomycosis and leukopenia, who was successfully treated with 5-aminolevulinic acid-based PDT (ALA-PDT). A complete cure, confirmed by clinical improvement and mycological detection, was achieved after six sessions of every-other-week treatment. Post six months follow up no recurrence was observed. The case here suggests that ALA-PDT is a valuable anti-infective therapy for refractory chromoblastomycosis.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ALA-PDT; Anti-infective; Chromoblastomycosis; Leukopenia

Year:  2019        PMID: 30769166     DOI: 10.1016/j.pdpdt.2019.02.013

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  5 in total

Review 1.  Photodynamic Therapy for the Treatment of Fungal Infections.

Authors:  Xuelin Wu; Yongxuan Hu
Journal:  Infect Drug Resist       Date:  2022-06-21       Impact factor: 4.177

2.  Antimicrobial and immunomodulatory responses of photodynamic therapy in Galleria mellonella model.

Authors:  Xiaowen Huang; Meinian Xu; Wen Pan; Menglei Wang; Xiaoyan Wu; Siqi Dai; Li Li; Kang Zeng
Journal:  BMC Microbiol       Date:  2020-07-06       Impact factor: 3.605

3.  Molecular Characteristics of Regional Chromoblastomycosis in Guangdong, China: Epidemiological, Clinical, Antifungal Susceptibility, and Serum Cytokine Profiles of 45 Cases.

Authors:  Hongfang Liu; Jiufeng Sun; Minying Li; Wenying Cai; Yangxia Chen; Yinghui Liu; Huan Huang; Zhenmou Xie; Weiying Zeng; Liyan Xi
Journal:  Front Cell Infect Microbiol       Date:  2022-02-18       Impact factor: 5.293

4.  Combination therapy for an elderly patient with chromoblastomycosis caused by Fonsecaea monophora: a case report.

Authors:  Yu Shen; Boxuan Jiang; Han Zhang; Jinrong Feng; Hui Hua
Journal:  Ann Transl Med       Date:  2022-01

5.  A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine.

Authors:  Xu-Cheng Shen; Xiang-Nong Dai; Zhi-Min Xie; Ping Li; Sha Lu; Jia-Hao Li; Yi Zhang; Xing-Dong Ye
Journal:  Dermatol Ther (Heidelb)       Date:  2020-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.